141 related articles for article (PubMed ID: 29534075)
21. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.
Mocellin S; Verdi D; Pooley KA; Landi MT; Egan KM; Baird DM; Prescott J; De Vivo I; Nitti D
J Natl Cancer Inst; 2012 Jun; 104(11):840-54. PubMed ID: 22523397
[TBL] [Abstract][Full Text] [Related]
22. Telomerase reverse transcriptase rs2736098 polymorphism is associated with lung cancer: A meta-analysis.
Wang M; Sun Y
J Int Med Res; 2020 Oct; 48(10):300060520936173. PubMed ID: 33044116
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
24. TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.
Zhang X; Chen Y; Yan D; Han J; Zhu L
Biochem Genet; 2022 Feb; 60(1):241-266. PubMed ID: 34181135
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
[TBL] [Abstract][Full Text] [Related]
26. Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.
Xia W; Xu Y; Mao Q; Dong G; Shi R; Wang J; Zheng Y; Xu L; Jiang F
Med Oncol; 2015 Feb; 32(2):442. PubMed ID: 25603950
[TBL] [Abstract][Full Text] [Related]
27. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
29. Association Between WRN Cys1367Arg (T>C) and Cancer Risk: A Meta-analysis.
Wang B; Li G; Sun F; Dong N; Sun Z; Jiang D
Technol Cancer Res Treat; 2016 Feb; 15(1):20-7. PubMed ID: 25468760
[TBL] [Abstract][Full Text] [Related]
30. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.
Shadrina AS; Boyarskikh UA; Oskina NA; Sinkina TV; Lazarev AF; Petrova VD; Filipenko ML
Tumour Biol; 2015 Feb; 36(2):841-7. PubMed ID: 25296732
[TBL] [Abstract][Full Text] [Related]
31. HLA-G +3142 C>G polymorphism and cancer risk: Evidence from a meta-analysis and trial sequential analysis.
Jiang Y; Li W; Lu J; Zhao X; Li L
Medicine (Baltimore); 2019 Jun; 98(25):e16067. PubMed ID: 31232944
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of possible role of the h
Yalınbaş Kaya B; Ülger Y
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):961-971. PubMed ID: 35704667
[TBL] [Abstract][Full Text] [Related]
33. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
34. ATM rs189037 (G > A) polymorphism increased the risk of cancer: an updated meta-analysis.
Zhao ZL; Xia L; Zhao C; Yao J
BMC Med Genet; 2019 Feb; 20(1):28. PubMed ID: 30709340
[TBL] [Abstract][Full Text] [Related]
35. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
[TBL] [Abstract][Full Text] [Related]
36. New evidence of TERT rs2736098 polymorphism and cancer risk: an updated meta-analysis.
Li T; Xian Y; Tian T; Zhuang X; Chu M
J BUON; 2016; 21(2):491-7. PubMed ID: 27273963
[TBL] [Abstract][Full Text] [Related]
37. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
[TBL] [Abstract][Full Text] [Related]
38. Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.
Cárcano FM; Vidal DO; van Helvoort Lengert A; Neto CS; Queiroz L; Marques H; Baltazar F; da Silva Martinelli CM; Soares P; da Silva EC; Lopes LF; Reis RM
Tumour Biol; 2016 Apr; 37(4):4901-7. PubMed ID: 26526580
[TBL] [Abstract][Full Text] [Related]
39. TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.
Wang HM; Zhang XY; Jin B
Genet Test Mol Biomarkers; 2013 Dec; 17(12):937-41. PubMed ID: 24283584
[TBL] [Abstract][Full Text] [Related]
40. TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.
Nie W; Zang Y; Chen J; Xiu Q
Tumour Biol; 2014 Jun; 35(6):5569-74. PubMed ID: 24535778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
